Relationships between C-reactive protein concentration and genotype in healthy volunteers

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 1, 2009, Pages 20-25

  Jones, Jennifer ^a   Chen, Li Sheng ^b   Baudhuin, Linnea ^b   Peterson, Sandra ^b   Harmsen, W Scott ^b   Zinsmeister, Alan R ^b   McConnell, Joseph ^b   Sandborn, William J ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b MAYO CLINIC   (United States)

Author keywords

Genotype; High sensitivity C reactive protein; Phenotype

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BODY MASS; CONTROLLED STUDY; DEMOGRAPHY; DYSLIPIDEMIA; FEMALE; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; INFECTION; LABORATORY TEST; MALE; NORMAL HUMAN; PHLEBOTOMY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP APNEA SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; C-REACTIVE PROTEIN; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58149234042     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.005     Document Type: Article

References (24)

1. Volkanis J. Human C-reactive protein: expression, structure and function. Mol Immunol 2001;38:189-97.
2. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-12.
3. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994;15:74-80.
4. Macy EM, Hayes TE, Tracey, RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference levels and epidemiological applications. Clin Chem 1997;43:52-8.
5. Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS. Acute phase inflammatory response to local periodontal disease and systemic conditions in the US population. J Dent Res 2000;79:49-57.
6. Szalai A. The biological functions of C-reactive protein. Vasc Pharmacol 2002;39:105-7.
7. Visser M, Bouter LM, McQuillan, Werner MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. J Am Med Assoc 1999;282:2131-5.
8. Haukim N, Bidwell JL, Smith AJ, Keen LJ, Gallagher G, Kimberly R, et al. Cytokine gene polymorphism in human disease: on-line databases, supplement 2. Genes Immun 2002;3:313-30.
9. Zee RY, Ridker PM. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 2002;162:217-9.
10. Brull DJ, Serrano N, Zito F, Jones L, Montgomery HE, Rumley A, et al. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 2003;23:2063-9.
11. Kovacs A, Green F, Hansson LO, Lundman P, Samnegard A, Boquist S, et al. A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis 2005;178:193-8.
12. Gander ML, Fischer JE, Maly FE, von Kanel R. Effect of the G-308A polymorphism of the tumor necrosis factor (TNF)-alpha gene promoter site on plasma levels of TNF-alpha and C-reactive protein in smokers: a cross-sectional study. BMC Cardiovasc Disord 2004;4:17.
13. Margaglione M, Bossone A, Cappucci G, Colaizzo D, Grandone E, Di Minno G. The effect of the interleukin-6 C/G -174 polymorphism and circulating interleukin-6 on fibrinogen plasma levels. Haematologica 2001;86:199-204.
14. Ferrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspan SL. Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 2003;88:255-9.
15. Kathiresan S, Larson MG, Vasan RS, Guo CY, Gona P, Keaney JF Jr, et al. Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 2006;113:1415-23.
16. Lakka HM, Lakka TA, Rankinen T, Rice T, Rao DC, Leon AS, et al. The TNF-alpha G-308A polymorphism is associated with C-reactive protein levels: the HERITAGE Family Study. Vasc Pharmacol 2006;44:377-83.
17. Sie MP, Sayed-Tabatabaei FA, Oei HH, Uitterlinden AG, Pols HA, Hofman A, et al. Interleukin 6 -174 G/C promoter polymorphism and risk of coronary heart disease: results from the Rotterdam study and a meta-analysis. Arterioscler Thromb Vasc Biol 2006;26:212-7.
18. Chen J, Zhao J, Huang J, Su S, Qiang B, Gu D. -717A>G polymorphism of human C-reactive protein gene associated with coronary heart disease in ethnic Han Chinese: the Beijing Atherosclerosis Study. J Mol Med 2005;83:72-8.
19. Vickers MA, Green FR, Terry C, Mayosi BM, Julier C, Lathrop M, et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002;53:1029-34.
20. Cao H, Hegele R. Human C-reactive protein (CRP) 1059G/C polymorphism. J Hum Genet 2000;45:100-1.
21. Eklund C, Kivimaki M, Islam MS, Juonala M, Kahonen M, Marniemi J, et al. C-reactive protein genetics is associated with carotid artery compliance in men in the Cardiovascular Risk in Young Finns Study. Atherosclerosis 2008;196:841-8.
22. Kivimaki M, Lawlor DA, Smith GD, Eklund C, Hurme M, Lehtimaki T, et al. Variants in the CRP gene as ameasure of lifelong differences in average C-reactive protein levels: the Cardiovascular Risk in Young Finns Study, 1980-2001. Am J Epidemiol 2007;166:760-4.
23. Kovacs A, Green F, Hansson LO, Lundman P, Samnegard A, Boquist S, et al. A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis 2005;178:193-8.
24. Jeanmonod P, von Kanel R, Maly FE, Fischer JE. Elevated plasma C-reactive protein in chronically distressed subjects who carry the A allele of the TNF-alpha -308 G/A polymorphism. Psychosom Med 2004;66:501-6.